These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2384229)

  • 1. Effect of exogenous apo E on the cellular binding of lipoproteins.
    Mokuno H; Ishibashi S; Shimano H; Gothoda T; Takaku F; Yamada N
    Gerontology; 1990; 36 Suppl 1():42-8. PubMed ID: 2384229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-very low density lipoprotein uptake in cultured fibroblasts and smooth muscle cells from Watanabe heritable hyperlipidemic rabbits.
    Wernette-Hammond ME; Garcia Z; Arnold KS; Innerarity TL
    Arteriosclerosis; 1989; 9(4):501-10. PubMed ID: 2546526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of canine beta-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor.
    Koo C; Wernette-Hammond ME; Innerarity TL
    J Biol Chem; 1986 Aug; 261(24):11194-201. PubMed ID: 3733751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Chappell DA
    J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.
    Fan J; Ji ZS; Huang Y; de Silva H; Sanan D; Mahley RW; Innerarity TL; Taylor JM
    J Clin Invest; 1998 May; 101(10):2151-64. PubMed ID: 9593771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enhanced cellular uptake of very-low-density lipoprotein enriched in apolipoprotein E.
    Mokuno H; Yamada N; Shimano H; Ishibashi S; Mori N; Takahashi K; Oka T; Yoon TH; Takaku F
    Biochim Biophys Acta; 1991 Feb; 1082(1):63-70. PubMed ID: 1849015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced metabolism of normolipidemic human plasma very low density lipoprotein in cultured cells by exogenous apolipoprotein E-3.
    Eisenberg S; Friedman G; Vogel T
    Arteriosclerosis; 1988; 8(5):480-7. PubMed ID: 3190555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells.
    Agnani G; Bard JM; Candelier L; Delattre S; Fruchart JC; Clavey V
    Arterioscler Thromb; 1991; 11(4):1021-9. PubMed ID: 2065026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low density lipoprotein receptor deficiency on the metabolism of apolipoprotein B-100 in blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits.
    Yamada N; Shames DM; Havel RJ
    J Clin Invest; 1987 Aug; 80(2):507-15. PubMed ID: 3611356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.
    Shimano H; Yamada N; Katsuki M; Yamamoto K; Gotoda T; Harada K; Shimada M; Yazaki Y
    J Clin Invest; 1992 Nov; 90(5):2084-91. PubMed ID: 1430232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
    Krul ES; Tikkanen MJ; Cole TG; Davie JM; Schonfeld G
    J Clin Invest; 1985 Feb; 75(2):361-9. PubMed ID: 3973009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular metabolism of human plasma intermediate-density lipoprotein (IDL).
    Friedman G; Gavish D; Vogel T; Eisenberg S
    Biochim Biophys Acta; 1990 May; 1044(1):118-26. PubMed ID: 2340301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of apo E-containing lipoproteins with the LDL receptor-related protein LRP.
    Küchenhoff A; Harrach-Ruprecht B; Robenek H
    Am J Physiol; 1997 Feb; 272(2 Pt 1):C369-82. PubMed ID: 9124278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of LDL receptor binding determinants in very low density lipoproteins.
    Bradley WA; Gotto AM; Gianturco SH
    Ann N Y Acad Sci; 1985; 454():239-47. PubMed ID: 3907464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages.
    Innerarity TL; Arnold KS; Weisgraber KH; Mahley RW
    Arteriosclerosis; 1986; 6(1):114-22. PubMed ID: 3942555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins.
    Koo C; Innerarity TL; Mahley RW
    J Biol Chem; 1985 Oct; 260(22):11934-43. PubMed ID: 2995353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.
    Schneider WJ; Kovanen PT; Brown MS; Goldstein JL; Utermann G; Weber W; Havel RJ; Kotite L; Kane JP; Innerarity TL; Mahley RW
    J Clin Invest; 1981 Oct; 68(4):1075-85. PubMed ID: 6270194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.
    Sehayek E; Lewin-Velvert U; Chajek-Shaul T; Eisenberg S
    J Clin Invest; 1991 Aug; 88(2):553-60. PubMed ID: 1864965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of apo E secretion on lipoprotein uptake in transfected cells.
    Shimano H; Fukazawa C; Shibasaki Y; Mori N; Gotoda T; Harada K; Shimada M; Yamada N; Yazaki Y; Takaku F
    Biochim Biophys Acta; 1991 Nov; 1086(3):245-54. PubMed ID: 1742315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.